Los Angeles, California


SYMPOSIUM INFORMATION

>General Information
>Faculty
>Program/Schedule
>Accreditation/CME Surveys
>Registration
>Privacy Policy
 

Check us out on Twitter!

@LA_HeartFailure
 

Sponsored by:
PIH Health Good Samaritan Hospital
Los Angeles, CA

Endorsed by:
CALIFORNIA CHAPTER OF THE
AMERICAN COLLEGE OF CARDIOLOGY



Affiliated With:
INTERNATIONAL ACADEMY OF CARDIOLOGY

Related Conferences:


25th Annual

Heart Failure 2021
An Update on Therapy
March 12 & 13, 2021

VIRTUAL EVENT

PROGRAM / SCHEDULE

All times are Pacific Standard Time (PST)

Friday, March 12, 2021

11:50-12:50
Product Theatre - Non-CME
The Next Horizon in the Heart Failure Treatment Paradigm for Patients With HFrEF
    Tania Gregorian, PharmD, BCACP
Sponsored by: AstraZeneca

12:50
Introduction/Program Overview
    Uri Elkayam, MD

1:00-1:20
Biomarkers for the Diagnosis and Management of Heart Failure.
     James Januzzi, MD

1:20-1:40
Prevention of Hyperkalemia as a Strategy for Optimization of Heart Failure Therapy
     Javed Butler, MD

1:40-2:00
EMPEROR-Reduced Trial: Effect of Empagliflozin on Cardiovascular and Renal Events in Heart Failure With a Reduced Ejection Fraction
     Milton Packer, MD

2:00-2:20
The Potential Role of Vericiguat in the Treatment of Heart Failure: Lessons From the VICTORIA and the VITALITY Trial
     Barry Greenberg, MD

2:20-2:40
Omecamtiv Mecarbil in Heart Failure: Where Does it Fit in the Management of Heart Failure?
     John R Teerlink, MD

2:40-3:00
New Drugs for the Management of HFrEF: A Welcome Addition or Polypharmacy Challenge?
    Gregg Fonarow, MD

3:00-3:10     Break/Visit Virtual Exhibit Hall

3:10-3:30
Recommendations for Genetic Testing in Patients with Cardiomyopathies
    William J. McKenna, MD 

3:30-3:50
Peripartum Cardiomyopathy: Treatment Considerations in the Context of Youth, Pregnancy, and Lactation
     Melinda Davis, MD

3:50-4:10
Left Ventricular Non Compaction: Diagnosis and Prognosis
     Jeffrey Towbin, MD

4:10-4:30
Considerations in the Selection of Available Drugs in Patients with TTR Amyloidosis
     Martha Grogan, MD  

4:30-4:50 
Ablation or Drug Therapy for Initial Treatment of Atrial Fibrillation?  Results of Recent Trials and Clinical Implications
    Anil Bhandari, MD

Saturday, March 13, 2021

7:00-8:00     Product Theatre - Non-CME
XARELTO, Advancements in VTE Prophylaxis of Acutely III Medical patients and Treatment of DVT/PE Hospital (ABV)
     Samuel A. Berkman, MD, FACP
Sponsored by: Janssen

8:00-8:10     Break/Visit Virtual Exhibit Hall

8:10-8:30
Myocardial Recovery Using LVAD – What Have We Learned & Future Directions? 
     Emma Birks, MD

8:30-8:50
Heart Failure with Recovered EF (HFrecEF): Definition, Natural History and Management Recommendations
     Uri Elkayam, MD

8:50-9:10
Clinical Approach to the HFpEF Patient
     Nancy Sweitzer, MD

9:10-9:30
More Lessons in the Use of Diuretics in Patients with Volume Overload
    Jeffrey Testani, MD  

9:30 -9:50
Interatrial Shunts for Heart Failure
     JoAnn Lindenfeld, MD

9:50-10:10
The Value of Pulmonary Artery Pressure-Guided Therapy for Heart Failure: Clinical Practice Experience
     Maria Rosa Constanzo, MD

10:10-10:20    Break/Visit Virtual Exhibit Hall

10:20-10:40
Digital Health Driven Heart Failure Program – The Role of Artificial Intelligence in Diagnosed and Managed Heart Failure
    Nir Uriel, MD

10:40-11:00
Conceptual Considerations for Device-Based Therapy for Acute Decompensated Heart Failure
     Hannah Rosenblum, MD 

11:00-11:20
Predictors of Clinical Response to Transcatheter Reduction of Functional Mitral Regurgitation
    Gregg Stone, MD 

11:20-11:40
Technical Challenges in Percutaneous Repair of Functional Mitral Regurgitation
     Steven Burstein, MD

11:40-12:00
Transcatheter Repair of Severe Tricuspid Regurgitation
    Samir Kapadia, MD 

12:00-12:20
Heart Failure Due to Low Flow, Low Gradient Aortic Stenosis: Mechanisms, Prognosis and Management
    Robert Bonow, MD

12:20-12:40
Intersection of Race and Heart Failure
    Ileana L. Piņa, MD

12:40-1:00     Break/Visit Virtual Exhibit Hall

1:00-1:30
L. Julian Haywood, MD Memorial Lecture
A Perspective: Equity in Medicine; Progress Noted; More Needed
    Clyde Yancy, MD

1:35-2:35     Product Theatre - Non-CME
A First-Choice Treatment for the Inpatient Management of Stabilized Systolic HF Patients: An Evidence-Based Approach
    Douglas Jennings, PharmD, FACC, FAHA, FCCP, FHFSA
Sponsored by: Novartis

2:40-3:40     Product Theatre - Non-CME
Selecting a Treatment for the Polyneuropathy of hATTR Amyloidosis
    Robert L. Gottlieb, MD, PhD, FACC
Sponsored by: Alnylam Pharmaceuticals